Top

Published in:

14-04-2022 | Literatur kommentiert

Einfluss der körperlichen Aktivität vor, während und nach der Chemotherapie auf die kognitive Leistungsfähigkeit bei Patientinnen mit Mammakarzinom: Ergebnisse einer prospektiven US-amerikanischen Studie

Authors: Assoz. Prof. Dr. Gerd Fastner, MSc, Assoz. Prof. Dr. F. Zehentmayr, MSc, MSc

Published in: Strahlentherapie und Onkologie | Issue 7/2022

Auszug

Die kognitive Leistungsfähigkeit (KL) kann bei bis zu 75 % der Patientinnen mit Mammakarzinom während einer Chemotherapie (CTX) eingeschränkt sein [1‐4]. Die vorliegende Arbeit verfolgte drei Fragestellungen: (1) Korreliert körperliche Aktivität (KA) während der CTX mit KL im zeitlichen Verlauf? (2) Hat KA vor CTX einen Einfluss auf die KL während und nach der Therapie? (3) Wie verändert sich die KA und deren Intensität bei Mammakarzinompatientinnen unter CTX im Vergleich zu einer unbehandelten Kontrollgruppe? …

Salerno EA, Culakova E, Kleckner AS, Heckler CE, Lin PJ, Matthews CE, Conlin A, Weiselberg L, Mitchell J, Mustian KM, Janelsins MC (2021) Physical activity patterns and relationships with cognitive function in patients with breast cancer before, during, and after chemotherapy in a prospective, nationwide study. J Clin Oncol 39(29):3283–3292. https://doi.org/10.1200/JCO.20.03514CrossRefPubMed

Janelsins MC, Heckler CE, Peppone LJ, Kamen C, Mustian KM, Mohile SG, Magnuson A, Kleckner IR, Guido JJ, Young KL, Conlin AK, Weiselberg LR, Mitchell JW, Ambrosone CA, Ahles TA, Morrow GR (2017) Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study. J Clin Oncol 35(5):506–514. https://doi.org/10.1200/jco.2016.68.5826CrossRefPubMed

Janelsins MC, Heckler CE, Peppone LJ, Ahles TA, Mohile SG, Mustian KM, Palesh O, O’Mara AM, Minasian LM, Williams AM, Magnuson A, Geer J, Dakhil SR, Hopkins JO, Morrow GR (2018) Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study. J Clin Oncol 36(32):JCO2018786624. https://doi.org/10.1200/jco.2018.78.6624CrossRef

Wagner MA, Erickson KI, Bender CM, Conley YP (2020) The influence of physical activity and epigenomics on cognitive function and brain health in breast cancer. Front Aging Neurosci 12:123. https://doi.org/10.3389/fnagi.2020.00123CrossRefPubMedPubMedCentral

Kohl HW, Paffenbarger RS et al (1997) The aerobics center longitudinal study physical activity questionnaire. Med Sci Sports Exerc 29:S10–S14

Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr., Tudor-Locke C, Greer JL, Vezina J, Whitt-Glover MC, Leon AS (2011) 2011 compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc 43(8):1575–1581. https://doi.org/10.1249/MSS.0b013e31821ece12CrossRefPubMed

Tudor-Locke C, Washington TL, Ainsworth BE, Troiano RP (2009) Linking the American time use survey (ATUS) and the compendium of physical activities: methods and rationale. J Phys Act Health 6(3):347–353. https://doi.org/10.1123/jpah.6.3.347CrossRefPubMed

Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, George SM, Olson RD (2018) The physical activity guidelines for americans. JAMA 320(19):2020–2028. https://doi.org/10.1001/jama.2018.14854CrossRefPubMed

Wagner LI, Sweet J, Butt Z et al (2009) Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy—cognitive function instrument. J Support Oncol 7:W32–W39

10.

Fray PJ, Robbins TW (1996) CANTAB battery: proposed utility in neurotoxicology. Neurotoxicol Teratol 18(4):499–504. https://doi.org/10.1016/0892-0362(96)00027-xCrossRefPubMed

11.

Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P (1994) Cambridge neuropsychological test automated battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 5(5):266–281. https://doi.org/10.1159/000106735CrossRefPubMed

12.

Wilkinson GS, Robertson GJ (2006) WRAT 4: wide range achievement test

13.

Spielberger C, Sydeman S, Owen A et al (1999) Measuring anxiety and anger with the state-trait anxiety inventory (STAI) and the state-trait anger expression inventory (STAXI). Lawrence Erlbaum, Mahwah, NJ

14.

Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL (1999) The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 85(5):1186–1196. https://doi.org/10.1002/(sici)1097-0142(19990301)85:5〈1186::aid-cncr24〉3.0.co;2‑nCrossRef

15.

Janelsins MC, Mustian KM, Palesh OG, Mohile SG, Peppone LJ, Sprod LK, Heckler CE, Roscoe JA, Katz AW, Williams JP, Morrow GR (2012) Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer 20(4):831–839. https://doi.org/10.1007/s00520-011-1158-0CrossRefPubMed

16.

Kesler SR, Blayney DW (2016) Neurotoxic effects of anthracycline- vs nonanthracycline-based chemotherapy on cognition in breast cancer survivors. JAMA Oncol 2(2):185–192. https://doi.org/10.1001/jamaoncol.2015.4333CrossRefPubMedPubMedCentral

17.

Cheung YT, Foo YL, Shwe M, Tan YP, Fan G, Yong WS, Madhukumar P, Ooi WS, Chay WY, Dent RA, Ang SF, Lo SK, Yap YS, Ng R, Chan A (2014) Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients. J Clin Epidemiol 67(7):811–820. https://doi.org/10.1016/j.jclinepi.2013.12.011CrossRefPubMed

18.

Costa DSJ, Fardell JE (2019) Why are objective and perceived cognitive function weakly correlated in patients with cancer? J Clin Oncol 37(14):1154–1158. https://doi.org/10.1200/JCO.18.02363CrossRefPubMed

19.

Brunt AM, Haviland JS, Kirby AM, Somaiah N, Wheatley DA, Bliss JM, Yarnold JR (2021) Five-fraction radiotherapy for breast cancer: FAST-forward to implementation. Clin Oncol 33(7):430–439. https://doi.org/10.1016/j.clon.2021.04.016CrossRef

20.

Bakoyiannis I, Tsigka EA, Perrea D, Pergialiotis V (2016) The impact of endocrine therapy on cognitive functions of breast cancer patients: a systematic review. Clin Drug Investig 36(2):109–118. https://doi.org/10.1007/s40261-015-0364-9CrossRefPubMed

21.

Ning S, Qiao K, Pan L (2022) Physical activity patterns and cognitive function in patients with breast cancer. J Clin Oncol. https://doi.org/10.1200/JCO.21.02073CrossRefPubMed

22.

Treanor CJ, McMenamin UC, O’Neill RF, Cardwell CR, Clarke MJ, Cantwell M, Donnelly M (2016) Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment. Cochrane Database Syst Rev 8:CD11325. https://doi.org/10.1002/14651858.CD011325.pub2CrossRef

Title: Einfluss der körperlichen Aktivität vor, während und nach der Chemotherapie auf die kognitive Leistungsfähigkeit bei Patientinnen mit Mammakarzinom: Ergebnisse einer prospektiven US-amerikanischen Studie
Authors: Assoz. Prof. Dr. Gerd Fastner, MSc
Assoz. Prof. Dr. F. Zehentmayr, MSc, MSc
Publication date: 14-04-2022
Publisher: Springer Berlin Heidelberg
Published in: Strahlentherapie und Onkologie / Issue 7/2022
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-022-01934-1

At a glance: The STEP trials

Springer Medicine

Einfluss der körperlichen Aktivität vor, während und nach der Chemotherapie auf die kognitive Leistungsfähigkeit bei Patientinnen mit Mammakarzinom: Ergebnisse einer prospektiven US-amerikanischen Studie

Auszug

At a glance: The STEP trials

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 7/2022

Reply to: Longer treatment time and lower radiation doses—an alternative for Graves’ ophthalmopathy treatment

Estimation of secondary cancer projected risk after partial breast irradiation at the 1.5 T MR-linac

Radiotherapy for vertebral hemangioma: the single-center experience of 80 patients

Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach

37. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik

Oligometastasis in breast cancer—current status and treatment options from a radiation oncology perspective

Estimation of secondary cancer projected risk after partial breast irradiation at the 1.5 T MR-linac